Leonard Schleifer
Chief Executive Officer at REGENERON PHARMACEUTICALS, INC.
Net worth: 2 157 M $ as of 30/04/2024
Leonard Schleifer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Chairman | 09/06/2023 | - |
| Chief Executive Officer | 08/01/1988 | - | |
| Founder | 08/01/1988 | - | |
| President | 08/01/1988 | - | |
| Director/Board Member | 01/01/1994 | 09/06/2023 | |
Regeneron Ireland DAC
 Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Chief Executive Officer | 01/01/2013 | - |
| Founder | 01/01/2013 | - | |
| President | 01/01/2013 | - |
Career history of Leonard Schleifer
Former positions of Leonard Schleifer
| Companies | Position | Start | End |
|---|---|---|---|
| Weill Cornell Medical College | Corporate Officer/Principal | - | - |
Training of Leonard Schleifer
| University of Virginia | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Ireland | 2 |
Operational
| Chief Executive Officer | 2 |
| Founder | 2 |
| President | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Health Technology |
- Stock Market
- Insiders
- Leonard Schleifer
- Experience